These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21570813)

  • 1. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin.
    Mortensen NP; Fowlkes JD; Maggart M; Doktycz MJ; Nataro JP; Drusano G; Allison DP
    Int J Antimicrob Agents; 2011 Jul; 38(1):27-34. PubMed ID: 21570813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteroaggregative Escherichia coli: surface protein dispersin increases bacterial uptake of ciprofloxacin.
    Mortensen NP; Boisen N; Carey S; Kennel SJ; Fowlkes JD; Doktycz MJ; Nataro JP; Allison DP
    Int J Antimicrob Agents; 2013 Nov; 42(5):462-5. PubMed ID: 24011504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.
    Wojnicz D; Jankowski S
    Int J Antimicrob Agents; 2007 Jun; 29(6):700-4. PubMed ID: 17382520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.
    Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J
    J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring cell surface elasticity on enteroaggregative Escherichia coli wild type and dispersin mutant by AFM.
    Beckmann MA; Venkataraman S; Doktycz MJ; Nataro JP; Sullivan CJ; Morrell-Falvey JL; Allison DP
    Ultramicroscopy; 2006; 106(8-9):695-702. PubMed ID: 16682120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistant enteroaggregative Escherichia coli diarrhoea in rural southern Indian population.
    Raju B; Ballal M
    Scand J Infect Dis; 2009; 41(2):105-8. PubMed ID: 19107675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli.
    Jerman B; Butala M; Zgur-Bertok D
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3087-90. PubMed ID: 15980407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
    Coban AY; Bayram Z; Sezgin FM; Durupinar B
    Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
    Wojnicz D; Cisowska A
    Int J Antimicrob Agents; 2009 Jun; 33(6):579-82. PubMed ID: 19232480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern.
    Aslani MM; Alikhani MY; Zavari A; Yousefi R; Zamani AR
    Int J Infect Dis; 2011 Feb; 15(2):e136-9. PubMed ID: 21130676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
    Hostacká A
    Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli.
    López E; Elez M; Matic I; Blázquez J
    Mol Microbiol; 2007 Apr; 64(1):83-93. PubMed ID: 17376074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Escherichia coli efflux pump TolC promotes aggregation of enteroaggregative E. coli 042.
    Imuta N; Nishi J; Tokuda K; Fujiyama R; Manago K; Iwashita M; Sarantuya J; Kawano Y
    Infect Immun; 2008 Mar; 76(3):1247-56. PubMed ID: 18160483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
    Dal SM; Bovio C; Culici M; Braga PC
    Drugs Exp Clin Res; 2002; 28(2-3):75-82. PubMed ID: 12224380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The majority of enteroaggregative Escherichia coli strains produce the E. coli common pilus when adhering to cultured epithelial cells.
    Avelino F; Saldaña Z; Islam S; Monteiro-Neto V; Dall'Agnol M; Eslava CA; Girón JA
    Int J Med Microbiol; 2010 Nov; 300(7):440-8. PubMed ID: 20452276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility to antimicrobial agents of enteroaggregative Escherichia coli strains isolated from children with diarrhea].
    Sobieszczańska B; Kowalska-Krochmal B; Mowszet K; Pytrus T
    Przegl Epidemiol; 2003; 57(3):499-503. PubMed ID: 14682169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.